Minderoo Precision Brain Tumour Programme
The Minderoo Precision Brain Tumour Programme is an exciting new clinical trial lead by Richard Mair at the CRUK-MInderoo Brain Cancer Virtual Institute.
Patients with suspected primary brain tumours are enrolled prior to surgery so that DNA and RNA from a sample of their tumour tissue can be sequenced.
These data are returned to the Brain - Genomics Tumour Advisory Board meeting to permit more accurate diagnostics, better prognostic information and stratification into molecularly targeted clinical trials.
The ICARUS Biorepository is a biobank that enables patients across Clinical Neurosciences to donate their tissues - Brain - Tumour - Biofluids - for current and future research.
The biobank exists adjacent to the neurosurgical operating theatres permitting rapid and secure storage of tissue.